4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly

benzinga.com The obesity market has garnered much interest lately, ever since Novo Nordisk NVO received FDA approval for its obesity drug Wegovy in 2021. It was only after a couple of…

The Oncology Institute, Inc. Reports Q1 Loss, Lags Revenue Estimates

benzinga.com The Oncology Institute, Inc. TOI came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.10 per…

Take-Two to Report Q4 Earnings: What's in Store?

benzinga.com Take-Two Interactive TTWO is set to report fourth-quarter fiscal 2024 results on May 16. For the fourth quarter of fiscal 2024, Take-Two expects GAAP net revenues between…

Merck Ends Keytruda Combo Melanoma Study Due to Futility

benzinga.com Merck MRK announced that it is discontinuing a cohort of the phase III study evaluating a co-formulation of its blockbuster PD-L1 inhibitor, Keytruda plus vibostolimab, its…

Alimera Sciences Reports Q1 Loss, Misses Revenue Estimates

benzinga.com Alimera Sciences ALIM came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.71 per share a…

Insulet Q1 Earnings Top, 2024 Revenue View Raised

benzinga.com Insulet Corporation PODD reported GAAP earnings per share of 73 cents for first-quarter 2024, which significantly improved from the year-ago period's EPS of 34 cents. The…

Brokers Suggest Investing in Netflix: Read This Before Placing a Bet

benzinga.com The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these…

Here's What Key Metrics Tell Us About Golden Entertainment Q1 Earnings

benzinga.com Golden Entertainment GDEN reported $174.05 million in revenue for the quarter ended March 2024, representing a year-over-year decline of 37.4%. EPS of -$0.37 for the same…

Accelerate Diagnostics Reports Q1 Loss, Misses Revenue Estimates

benzinga.com Accelerate Diagnostics AXDX came out with a quarterly loss of $0.88 per share versus the Zacks Consensus Estimate of a loss of $0.72. This compares to loss of $1.70 per…

Cytek Biosciences, Inc. Reports Q1 Loss, Tops Revenue Estimates

benzinga.com Cytek Biosciences, Inc. CTKB came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to break-even earnings…

A Look at Pharma ETFs Post Q1 Earnings

benzinga.com The first-quarter results of the healthcare sector have been unimpressive, with earnings of 78% of the sector participants that have reported so far down 31.2% despite 4.4%…

Perrigo Q1 Earnings Surpass, Sales Miss Estimates

benzinga.com Perrigo Company plc PRGO reported adjusted earnings of 29 cents per share in the first quarter of 2024, beating the Zacks Consensus Estimate of 24 cents. Earnings were down…

Inspire Medical Q1 Earnings Beat, Gross Margin Up

benzinga.com Inspire Medical Systems, Inc. INSP delivered a loss per share of 34 cents in first-quarter 2024, narrower than the year-ago period's loss of 53 cents per share. The metric…

4 Sector ETFs & Stocks Likely to Benefit Despite Soft Jobs Data

benzinga.com The U.S. economy added 175,000 jobs in April, well below Wall Street expectations of 240,000, strengthening bets that the Federal Reserve will be able to cut interest rates…

Roblox to Report Q1 Earnings: What's in the Cards?

benzinga.com Roblox RBLX is set to report first-quarter 2024 results on May 9. The Zacks Consensus Estimate for revenues is pegged at $931.05 million, indicating growth of 20.32% from…

BioCryst Pharmaceuticals Reports Q1 Loss, Tops Revenue Estimates

benzinga.com BioCryst Pharmaceuticals BCRX came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.28 per…

Omega Therapeutics, Inc. Reports Q1 Loss, Tops Revenue Estimates

benzinga.com Omega Therapeutics, Inc. OMGA came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to loss of $0.50 per…

Fox to Report Q3 Earnings: What's in the Offing?

benzinga.com Fox FOXA is set to report third-quarter fiscal 2024 results on May 8. For the quarter, the Zacks Consensus Estimate for earnings is pegged at $1.16 per share, up 0.9% in the…

Moves 7.1% Higher: Will This Strength Last?

finance.yahoo.com shares ended the last trading session 7.1% higher at $111.75. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the…